Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma

Fig. 4

Figures showing intensity quantification results of CXCL1 and IL6 for Group 3 MB from the blot analysis in (A) and (B) respectively. Similar to the IL8 findings, the 2 Group 3, MYC-amplified MB patients express higher CXCL1 and IL6 in their CSF compared to the rest of Group 3 MB samples. CXCL1 and IL6 do not show sufficient expression in the Group 4 MB cohort after normalization to internal controls

Back to article page